Professor Neil Kelleher is driving to make top down proteomics a more efficient and productive approach. [ + ]

Professor Neil Kelleher is using his top down proteomics approach to discover new biomarkers for disease. [ + ]

Despite a number of new hospital brands to be launched targeting serious infections caused by multidrug-resistant bacteria, there will be a market decline caused by genericisation, safety concerns and resistance of leading antibacterial brands.

Australian researchers have discovered a subset of regulatory T cells that keep the immune system in a fine balance. [ + ]

Professor John Quackenbush has been offered an Australian Fellowship to join the University of Queensland's Institute for Molecular Bioscience.

Pilot trials of Clinuvel’s skin repigmentation treatment, Scenesse (afamelanotide), will begin in the US and Europe to treat vitiligo. [ + ]

The Australian Academy of Science and AusBiotech have both spoken out against the proposed amendment to the patent act that would ban patenting any biological materials. [ + ]

The United Nations has declared 2011 the International Year of Chemistry, which includes an international initiative that highlights the role chemistry plays in issues of water quality and purification.

The recommendations of the Clinical Trials Action Group have been accepted by the federal government, and the changes will have a positive effect on pharmaceutical research and development and will improve the clinical trials approval process.

The federal government will overhaul the clinical trials process in Australia after accepting recommendations of the long awaited Clinical Trials Action Group report. [ + ]

The licensing system for creating stem cells is preventing potentially life saving research and should be streamlined, say Australian stem cell researchers. [ + ]

Hach Company has acquired Accurate Detection and Accurate Measurement.

Australian patent issued for Imm-255, which is an orally administered anti-influenza candidate. [ + ]

Scientists have solved the mystery of the main structural component of elastin and the discovery could lead to major advances in the treatment of burns victims, among others.

The Australian Synchrotron has announced four new senior appointments, including Professor Keith Nugent as Director, and a reorganisation of senior responsibilities.